Amid the surging wave of innovation in China's biopharmaceutical industry, a decade is long enough to witness the full evolution of a sector-from its initial emergence and growth to fundamental ...

In an era where AI-driven drug discovery accelerates candidate generation faster than traditional systems can evaluate them, ...

AstraZeneca entered a strategic collaboration with CSPC Pharmaceuticals to expand its weight management and metabolic disease ...

AI has been hailed as a way to speed up historically sluggish drug development, but an entirely AI-designed drug has yet to be approved by the FDA. The furthest along is likely Insilico Medicine’s ...

AstraZeneca has unveiled a tie-up with China’s CSPC Pharmaceutical Group to ramp up development of experimental weight loss and diabetes drugs in a deal worth $18.5bn (£13.4 billion) as it looks to ...

The deal includes giving AstraZeneca access to the exclusive global rights, outside China, to CSPC’s once-a-month weight ...

India is all set to witness the announcement of Union budget 2026-27. In this article, we explore what healthcare and pharma ...

CHENGDU CITY, SICHUAN PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The digital printing industry continues ...

ZUNYI CITY, GUIZHOU, CHINA, January 16, 2026 /EINPresswire.com/ -- In recent years, the pharmaceutical, food, and ...

Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...

AstraZeneca's investment coincides with China’s burgeoning presence in the pharmaceutical industry, driven by an uptick in innovative medicines R&D.

TOKYO, JAPAN, January 14, 2026 / EINPresswire.com / — LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in OmicInsight Corporation ...